KarunaGaneshMDPhD

Hematologic Oncology

Assistant Member, Molecular Pharmacology Program and GI Oncology Service, Director of Metastasis Research, Center for Colorectal Cancer, Memorial Sloan Kettering Cancer Center, Assistant Professor, Weill Cornell Medical College

Request Appointment

Overview of Dr. Ganesh

Dr. Karuna Ganesh is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from School of Clinical Medicine, University of Cambridge and has been in practice 7 years. She is one of 503 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 40 publications and over 500 citings.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(231) 674-7758

Education & Training

University of Cambridge School of MedicineClass of 2010
School of Clinical Medicine, University of CambridgeClass of 2010
Beth Israel Deaconess Medical CenterResidency, Internal Medicine

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2015 - 2026
NJ State Medical License 2019 - 2025
MA State Medical License 2011 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.
Roni Y Rosen, Aron P Bercz, Dana M Omer, Floris S Verheij, Hannah Williams
Diseases of the Colon and Rectum. 2025-03-01
Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal...
Ahmed Mahmoud, Philip H Choi, Christine Sukhwa, Jura Pintar, Henry Walch
Biorxiv. 2025-02-22
1 citations
Inferring cancer type-specific patterns of metastatic spread using Metient.
Divya Koyyalagunta, Karuna Ganesh, Quaid Morris
Biorxiv. 2025-02-03

Press Mentions

The Gut Microbiome and Cancer: MSK Researchers Present New FindingsApril 19th, 2023
Memorial Sloan Kettering Scientists Identify Potential New Strategy Against MetastasisMarch 29th, 2023
The Pershing Square Sohn Cancer Research Alliance Awards $4.2M to Seven Emerging Trailblazers in Cancer ResearchJune 7th, 2022
Join now to see all

Grant Support

Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem CellsSLOAN-KETTERING INST CAN RESEARCH2022–2027
Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem CellsSLOAN-KETTERING INST CAN RESEARCH2022–2027
Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem CellsSLOAN-KETTERING INST CAN RESEARCH2022–2027
Mechanisms of Dynamic Transcriptional Reprogramming in Metastasis Stem CellsSLOAN-KETTERING INST CAN RESEARCH2022–2027
Functional modeling of race-specific features underlying phenotypic reprogramming in metastatic stem cells from colorectal cancer patientsSLOAN-KETTERING INST CAN RESEARCH2024–2026
Functional modeling of race-specific features underlying phenotypic reprogramming in metastatic stem cells from colorectal cancer patientsSLOAN-KETTERING INST CAN RESEARCH2024–2026
Dissect the molecular mechanism of ZFP36L2-mediated cell fate plasticitySLOAN-KETTERING INST CAN RESEARCH2022–2026
Dissect the molecular mechanism of ZFP36L2-mediated cell fate plasticitySLOAN-KETTERING INST CAN RESEARCH2022–2026
Dissect the molecular mechanism of ZFP36L2-mediated cell fate plasticitySLOAN-KETTERING INST CAN RESEARCH2022–2026
Dissect the molecular mechanism of ZFP36L2-mediated cell fate plasticitySLOAN-KETTERING INST CAN RESEARCH2022–2026